Most people know the big names—THC and CBD. But the cannabis plant actually produces over a hundred different cannabinoids, many of which scientists are only beginning to understand. Companies like Rare Cannabinoid Company are betting that the future of cannabis products will come from exploring those lesser-known compounds.
Instead of focusing on just one ingredient, the company builds products that combine multiple cannabinoids—things like CBC, CBG, CBN, THCV, and CBD—with low doses of THC. The idea is that different combinations may support different experiences, whether that’s relaxation, sleep, energy, or recovery.
One example is their line of gummies and tinctures that mix cannabinoids together to create specific effects. Some formulas aim to support mood, while others lean toward sleep or physical recovery. These products are typically derived from hemp and formulated to stay within federal legal limits for THC.
The company’s broader philosophy is that cannabis isn’t a one-compound plant. Instead, they treat it more like a toolbox of chemical building blocks, where different cannabinoids can be combined and customized depending on what someone is looking for.
It’s a different approach from the old-school cannabis market that focused almost entirely on how high the THC percentage was.
Instead, the bet here is that the future of cannabis products might look more like a personalized cannabinoid menu—a little THC here, some CBN for sleep there, maybe a dash of THCV for energy.
In other words, the next evolution of cannabis might not just be stronger weed.
Dabbin-Dad Newsroom
